17, 2005 – Irvine, CA: TRIMEDYNE, INC. (OTCBB “TMED”) today announced it
entered into a License Agreement with Northwestern University, Evanston, IL,
under which Trimedyne acquired an exclusive license to the Hydrostat invented by
John Pandolfino, M.D. and
others of the Gastroenterology Department of the University’s Medical
Hydrostat measures the resistance (opening pressure) of the sphincter valve of
the esophagus. If the resistance is too low, acid in the stomach may enter
the esophagus causing gastro esophageal reflux disease or GERD, commonly known
as “heartburn.”http://www.trimedyne.com/press68.htm If not treated,
damage to the esophagus over time may lead to esphageal
cancer, an often fatal condition.
has begun the development of a new, small laser and disposable fiber optic device to shrink
esophagus to tighten the sphincter and increase its resistance, preventing
stomach acid from entering the esophagus. The
Hydrostat shows the physician the sphincter has been sufficiently tightened.
estimated 21 million people in the United States and millions more outside the U.S. suffer from GERD.
Drugs and OTC medications that treat the discomfort, but not the cause of
GERD, must be used by 25 to 50% of GERD patients for the rest of their lives.
Injections of polymers are successful in only some patients, and staples
to cinch the esophagus may
cause bleeding and pain. Although
symptoms can be controlled with medications, cure
for GERD is surgically wrapping a portion of
around the lower
of the esophagus and sewing it into
laser procedure to treat GERD is being
designed to be performed through a flexible endoscope
on an outpatient
basis. Clinical trials must be
successfully concluded before an application for clearance to market
Trimedyne’s new laser, fiber optic device and the
Hydrostat can be filed with the U.S.
Trimedyne manufactures lasers and proprietary
fiber optic devices for a variety of minimally invasive surgical procedures,
many of which are performed on an outpatient basis at substantially less cost
than conventional surgery. For
product, financial and other information, visit Trimedyne's website, http://www.trimedyne.com.